Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome® Post LB on IBS Gastrointestinal Symptoms | MicrobiomeTrials← Back to trialsNCT06889779
Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome® Post LB on IBS Gastrointestinal Symptoms
CompletedNAINTERVENTIONAL
Trial Details
Start: 2025-03-27Est. Completion: 2026-06-06
Enrollment target: 353 participants Locations- Shri. B. M. PatilMedical College,Hospital andResearch Centre, Vijayapura, Karnataka, India
- Shivam Hospital, Dombivali, Maharashtra, India
- Aster Aadhar Hospital, Kolhāpur, Maharashtra, India
- D Y Patil, Navi Mumbai, Maharashtra, India
- Dhanwantari Hospital, Pune, Maharashtra, India
- Silver Birch, Pune, Maharashtra, India
- Vishwaraj hospital, Pune, Maharashtra, India
- D Y Patil Hospital, Medical college and research centre, Thane, Maharashtra, India
- Dr. Naresh Bansal's Gastro & Liver Clinic, New Delhi, National Capital Territory of Delhi, India
- Jaipur National University Institute of Medical Sciences and Research Centre, Jaipur, Rajasthan, India
- Samvedna Hospital, New Colony, Ravindrapuri Varanasi, India
- Gleneagles Global Hospitals, Hyderabad, Telangana, India
Other microbiome trials you might be interested in
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), characterized by the Rome IV criteria, is a functional bowel disorder combining abdomina…
Lyon, FranceEst. completion Oct 10, 2028
Intestinal Disease
The gut microbiota plays a crucial role in human health, influencing metabolism, immunity, and pathogen resistance. Rese…
Rome, ItalyEst. completion Mar 10, 2027
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that substantially affects quality of li…
Istanbul, Turkey (Türkiye)Completed Nov 25, 2021